Home › NDC Lookup › RxCUI directory › RxCUI 197726

Flutamide 125 MG Oral Capsule — RxCUI 197726

RxNorm drug concept · Semantic clinical drug
RxCUI 197726 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197726
Official nameFlutamide 125 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Flutamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats prostate cancer in men and is taken together with an LHRH-agonist. Eulexin is used for early-stage disease around radiation and for cancer that has spread.
  • You take the capsules by mouth, spaced evenly through the day. Food doesn't change how it's absorbed. Follow your prescriber's schedule and the label exactly.
  • Hot flashes, lower sex drive, impotence, diarrhea, and nausea are common. Many come from the hormone-lowering treatment itself. Tell me if diarrhea becomes severe.
  • Flutamide can injure the liver, sometimes seriously. We check liver tests before you start, monthly for 4 months, and periodically after that. Call your doctor right away for yello...
📖 Read our full Flutamide guide →

🕸️ Concept Web — How Flutamide 125 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Flutamide 125 MG Oral Capsule RxCUI 197726

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Flutamide 4508
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Eulexin 151668
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Flutamide Oral Capsule 372251
    • Flutamide Oral Product 1161458
    • Flutamide Pill 1161459
    • Flutamide Oral Capsule [Eulexin] 366776
    • Eulexin Oral Product 1171155
    • Eulexin Pill 1171109
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Flutamide 125 MG SCDC · 315960
  • Flutamide Oral Capsule SCDF · 372251
  • Flutamide Oral Product SCDG · 1161458
  • Flutamide Pill SCDG · 1161459

Brand-Name Concepts

  • Flutamide 125 MG Oral Capsule [Eulexin] SBD · 205646
  • Flutamide 125 MG [Eulexin] SBDC · 566538
  • Flutamide Oral Capsule [Eulexin] SBDF · 366776
  • Eulexin Oral Product SBDG · 1171155
  • Eulexin Pill SBDG · 1171109
  • Eulexin BN · 151668

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 197726 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80725-0143-18 1 BOTTLE, PLASTIC in 1 BOX (80725-143-18) / 180 CAPSULE in... Eulexin Waylis Therapeutics LLC 2021-11-12
80725-0600-18 1 BOTTLE, PLASTIC in 1 BOX (80725-600-18) / 180 CAPSULE in... Eulexin Waylis Therapeutics LLC 2021-11-12
Observed labelers: Waylis Therapeutics LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.